Morphine-induced behavioral sensitization increased the mRNA expression of NMDA receptor subunits in the rat amygdala

Zargham Sepehrizadeh1, Mousa Sahebgharani, Shamseddin Ahmadi

  • 1Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Tehran, Tehran, Iran.

Pharmacology
|April 9, 2008
PubMed

Insights

Repeated morphine treatment induces behavioral sensitization in rats, increasing NMDA receptor mRNA in the amygdala. The NMDA receptor antagonist MK801 did not affect this sensitization but impacted memory retrieval.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Repeated morphine administration can lead to behavioral sensitization, a phenomenon where drug effects are potentiated.
  • The N-methyl-D-aspartate (NMDA) receptor system is implicated in drug addiction and plasticity.
  • Understanding the molecular mechanisms underlying morphine-induced behavioral sensitization is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the effect of repeated morphine treatment on rat behavior, focusing on locomotion, oral stereotypy, and state-dependent memory.
  • To examine the role of the NMDA receptor antagonist MK801 in morphine-induced behavioral sensitization.
  • To analyze the changes in mRNA expression of NMDA receptor subunits (NR1 and NR2A) in specific brain regions following chronic morphine exposure.

Main Methods:

  • Rats received repeated morphine administration followed by washout periods of 24 hours or 7 days.
  • Behavioral tests included locomotion, oral stereotypy, and a passive avoidance test for state-dependent memory.
  • MK801, an NMDA receptor antagonist, was administered before test doses of morphine.
  • Quantitative real-time RT-PCR was used to measure mRNA expression of NMDA receptor subunits in brain regions like the amygdala, striatum, prefrontal cortex, hippocampus, and hypothalamus.

Main Results:

  • A 7-day washout period after chronic morphine treatment induced behavioral sensitization, potentiating responses to test doses of morphine.
  • MK801 (0.1 and 0.25 mg/kg) did not attenuate locomotion or oral stereotypy in the sensitized state.
  • Higher doses of MK801 impaired morphine-induced memory retrieval, potentially due to motor effects.
  • Morphine sensitization significantly increased NR1 (104%) and NR2A (85%) mRNA expression in the amygdala, with no changes in other brain areas or in non-sensitized animals.

Conclusions:

  • MK801 does not influence the expression phase of morphine-induced behavioral sensitization.
  • Increased NMDA receptor subunit mRNA expression in the amygdala is associated with morphine-induced behavioral sensitization.
  • The amygdala plays a role in the neurobiological underpinnings of morphine sensitization.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...